CARAT Fellowships for a training course

CARAT invites five scientists to participate in a unique training event at Miltenyi Biotec which has the aim of transferring knowledge on GMP compliant CAR T cell manufacturing to scientists in the field. Scientists with a profound background in cellular and gene therapy who intend to initiate clinical applications in the near future can apply for the fellowship.

The EU-funded project Chimeric Antigen Receptors (CARs) for Advanced Therapies (CARAT) aims to develop a new, comprehensive platform for innovative cell manufacturing technologies as part of the European Horizon 2020 research and innovation programme. In order to accomplish the goal of providing a safe, automated, and cost-efficient manufacture of effective CAR T cells for personalised cancer therapies, CARAT, consisting of eight partners from four different European countries, was initiated. Within the framework of CARAT, a training course on GMP compliant CAR T cell manufacturing will be organised. This training event will take place in December 2017 at Miltenyi Biotec’s headquarters in Bergisch Gladbach, Germany.

Read more:
CARAT Fellowships for a training course